Clinical Trial Update: Pharmacodynamics of Nasal and Buccal Midazolam Using EEG [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the pharmacodynamics of nasal and buccal midazolam using EEG in epilepsy. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Columbia University | Conditions: Epilepsy | Phase 1 | Status: TERMINATED